APA (7th ed.) Citation

K, N., E, T., J, S., A, R., M, P. C., A, K., . . . M, L. (2025). Remdesivir is active in vitro against tick-borne encephalitis virus and selects for resistance mutations in the viral RNA-dependent RNA polymerase. Infectious diseases (London, England), 57(7), 628. https://doi.org/10.1080/23744235.2025.2468510

Chicago Style (17th ed.) Citation

K, Nyström, et al. "Remdesivir Is Active In vitro Against Tick-borne Encephalitis Virus and Selects for Resistance Mutations in the Viral RNA-dependent RNA Polymerase." Infectious Diseases (London, England) 57, no. 7 (2025): 628. https://doi.org/10.1080/23744235.2025.2468510.

MLA (9th ed.) Citation

K, Nyström, et al. "Remdesivir Is Active In vitro Against Tick-borne Encephalitis Virus and Selects for Resistance Mutations in the Viral RNA-dependent RNA Polymerase." Infectious Diseases (London, England), vol. 57, no. 7, 2025, p. 628, https://doi.org/10.1080/23744235.2025.2468510.